-
Nuvation Bio Announces Expanded Access Program in the U.S. for Taletrectinib in Advanced ROS1-positive Non-Small Cell Lung Cancer
03 Feb 2025 13:14 GMT
… positive (ROS1+) non-small cell lung cancer (NSCLC) when no comparable … a rare form of lung cancer with a unique patient … the most common form of lung cancer. It is estimated that … emergence or worsening of adverse events or other undesirable side …
-
CHMP Issues Positive Opinion For Subcutaneous RYBREVANT®(Amivantamab) Co-Formulated With ENHANZE® For The Treatment Of Patients With Advanced EGFR-Mutated Non-Small Cell Lung Cancer
03 Feb 2025 13:14 GMT
… with advanced non-small cell lung cancer (NSCLC) with epidermal growth … –Mutated Non–Small Cell Lung Cancer: Primary Results From the … press release, unexpected adverse events or patient experiences or … -looking statements to reflect events after the date of …
-
Characteristics, Incidence, and Management of Immune Checkpoint Inhibitors Related Cardiovascular Adverse Events in Real-World Practice-A Retrospective Study in Chinese Han Population
03 Feb 2025 12:14 GMT
… malignancies, especially for lung cancer, hepatocellular carcinoma, as … CVAE, cardiovascular adverse event.
The demographic and … adverse cardiovascular events in patients with lung cancer. JACC CardioOncol … risk assessment in lung cancer patients treated with …
-
Median Technologies: eyonis™ Lung Cancer Screening (LCS) Meets Primary Endpoint in RELIVE Clinical Trial, the Final Pivotal Study Required for Regulatory Submissions
03 Feb 2025 06:15 GMT
… tomography (LDCT) scans for lung cancer screening.
Lung cancer is the number one killer … providers.
About lung cancer screening in the U.S.: Lung cancer screening is … respect to future financial results, events, operations, services, product development …
-
Data Help Refine Optimal Radiotherapy Approaches in Small Cell Lung Cancer
02 Feb 2025 00:22 GMT
… Annual Winter Lung Cancer Conference®, an event held by … lung cancer field.
References
Curran W. Limited-stage small cell lung cancer … 2025. Presented at: 22nd Annual Winter Lung Cancer … limited small-cell lung cancer treated concurrently with …
-
Grandmother-to-be never smoked but got lung cancer. She turned to a cutting-edge option
01 Feb 2025 15:09 GMT
… importance of life-saving lung cancer screenings
02:58
Last … 39; I never expected lung cancer."
Lung cancer in "never-smokers … caused her own illness.
Lung cancer is the deadliest cancer … Digital. She covers current events, breaking news and issues …
-
TROPION-Lung12 Phase 3 Trial Initiated Evaluating DATROWAY® as Part of Adjuvant Regimen for Patients with Early-Stage Non-Small Cell Lung Cancer at High Risk of Relapse
31 Jan 2025 04:08 GMT
… 1 adenocarcinoma non-small cell lung cancer (NSCLC) after complete … -Small Cell Lung Cancer
Nearly 2.5 million lung cancer cases were … with Grade 3-4 events. Median time to first … Institute. Non-Small Cell Lung Cancer Treatment (PDQ®)–Health Professional …
-
FDA Grants Orphan Drug Designation to ZL-1310 for Treatment of Small Cell Lung Cancer
29 Jan 2025 16:43 GMT
… toxicities, treatment-related adverse events (AEs) of grade 3 … the treatment of small cell lung cancer (SCLC). BusinessWire. News Release … the-Treatment-of-Small-Cell-Lung-Cancer-SCLC
2. Halpern L … in subjects with small cell lung cancer. Euro Journ Cancer. …
-
OS Therapies Agrees to Acquire All Listeria Monotygenes-based Immuno-Oncology Programs and IP Assets from Ayala Pharmaceuticals, Adding Phase 2 Lung Cancer and Phase 1 Prostate Cancer Programs to Pipeline
29 Jan 2025 15:09 GMT
… outcomes worldwide.”
Lung Cancer Asset Clinical Data
Lung Cancer
ASCO 2022 Poster … metastatic non-small cell lung cancer either progressing on … : NCT03847519.
The global lung cancer treatment market size was … because they relate to events and depend on …
-
ImmunityBio Announces Collaboration with BeiGene on Confirmatory Phase 3 Trial of ANKTIVA® and PD-1 Checkpoint Inhibitor Combination in Non-Small Cell Lung Cancer
29 Jan 2025 13:48 GMT
… to the American Cancer Society, lung cancer is the second most common … for about 87% of all lung cancer diagnoses, and there are … we hope to help metastatic lung cancer patients who may have few … ImmunityBio with respect to future events and are subject to …
About
© 1995-2025